SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:DiVA.org:umu-161631"
 

Sökning: onr:"swepub:oai:DiVA.org:umu-161631" > Deficient mismatch ...

Deficient mismatch repair as a prognostic marker in stage II colon cancer patients

Gkekas, Ioannis, (författare)
Umeå universitet, Kirurgi, Clister
Novotny, Jan, (författare)
Umeå universitet, Kirurgi
Fabian, Pavel, (författare)
Department of Oncological Pathology, Masaryk Memorial Cancer Institute, Brno, Czech Republic
visa fler...
Nemecek, Radim, (författare)
Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic
Palmqvist, Richard, (författare)
Umeå universitet, Patologi
Strigård, Karin, (författare)
Umeå universitet, Kirurgi, Clister
Pecen, Ladislav, (författare)
Faculty Hospital Pilsen, Charles University, Prague, Czech Republic
Svoboda, Tomas, (författare)
Faculty Hospital Pilsen, Charles University, Prague, Czech Republic
Gurlich, Robert, (författare)
Department of Surgery, University Hospital Kralovske Vinohrady, Prague, Czech Republic
Gunnarsson, Ulf, (författare)
Umeå universitet, Kirurgi, Clister
visa färre...
Umeå universitet Medicinska fakulteten. Institutionen för kirurgisk och perioperativ vetenskap. Kirurgi. (creator_code:org_t)
Umeå universitet Medicinska fakulteten. Institutionen för medicinsk biovetenskap. Patologi. (creator_code:org_t)
2019
Engelska.
Ingår i: European Journal of Surgical Oncology. - Elsevier. - 0748-7983. ; 45:10, s. 1854-1861
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • BACKGROUND: A number of reports have evaluated the relationship between deficient DNA mismatch repair (dMMR) and colorectal cancer prognosis. Unfortunately, the exact prognostic role of dMMR has not been clearly established due to contradictory results. This study aims to determine the prognostic impact of dMRR in stage II colon cancer patients only. The appropriate identification of high-risk stage II colon cancers is of paramount importance in the selection of patients who may benefit from adjuvant treatment after surgery.METHODS: Four hundred and fifty-two patients with curative resection of stage II colon cancer were included. Hospital records were used as data source, providing clinical, surgical, pathology, oncology and follow-up information for statistical analysis focusing on overall survival (OS) and time to progression (TTP). Mismatch repair status was determined by immunohistochemistry. Patient survival was followed-up for a mean of 77·35 months.RESULTS: dMMR was detected in 93 of 452 patients (20·6%). No impact on overall survival (Log-Rank, p = 0·583, 95% CI 0·76-1·67). However, the hazard ratio 0·50 for TTP was highly significant (Log-Rank, p = 0·012, 95% CI 0·28-0·87) in patients with dMMR compared with those with mismatch repair proficient tumours (pMMR).CONCLUSIONS: Patients with dMMR tumours have a lower risk for recurrence compared to those with pMMR tumours, but this finding did not correlate to better overall survival.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Kirurgi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Surgery (hsv//eng)

Nyckelord

Colon cancer
Prognostic factors
Stage II
dMMR

Publikations- och innehållstyp

art (ämneskategori)
ref (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy